Drug General Information
Drug ID	D0F3ZO
Former ID	DNC003601
Drug Name	2-(phosphonomethyl)pentanedioic acid
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529200]
Structure		Download 2D MOL 3D MOL
Formula	C6H11O7P
Canonical SMILES	C(CC(=O)O)C(CP(=O)(O)O)C(=O)O
InChI	1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13)
InChIKey	ISEYJGQFXSTPMQ-UHFFFAOYSA-N
PubChem Compound ID	10130754
Target and Pathway
Target(s)	Glutamate carboxypeptidase II	Target Info	Inhibitor	[529200]
KEGG Pathway	Alanine, aspartate and glutamate metabolism
	Metabolic pathways
	Vitamin digestion and absorption
NetPath Pathway	TCR Signaling Pathway
	TNFalpha Signaling Pathway
Reactome	Amino acid synthesis and interconversion (transamination)
WikiPathways	One Carbon Metabolism
References
Ref 529200	Bioorg Med Chem. 2008 Feb 15;16(4):1648-57. Epub 2007 Nov 17.Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer.
Ref 529200	Bioorg Med Chem. 2008 Feb 15;16(4):1648-57. Epub 2007 Nov 17.Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.